The problem is obtaining knowledge: a qualitative analysis of provider barriers and accelerators to rapid adoption of new treatment in a public health emergency
Abstract Granted by the U.S. Food and Drug Administration, an Emergency Use Authorization (EUA) can only be utilized upon declaration that a specialized set of circumstances exist which justify the authorization. In 2020, the COVID-19 pandemic demanded rapid communication strategies to promote treat...
Main Authors: | Stuart H. Williams, Megan D. McFarlane, Mary Giammarino, Jamie Oleksa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12889-022-14890-3 |
Similar Items
-
Integration Of Travel Time Zone For Optimal Siting Of Emergency Facilities
by: Indriasari, Vini
Published: (2008) -
Mário Pedrosa e a construção do espaço imperial dos EUA sob o capitalismo monopolista
by: Everaldo Oliveira Andrade
Published: (2017-08-01) -
The evidence base for emergency use authorizations for COVID‐19 treatments: A rapid review
by: Catherine Knowlson, et al.
Published: (2023-01-01) -
Parent’s Hesitation with COVID-19 Vaccinations in Infants and Children Aged 6 Months to 5 Years
by: Austin M. Temple, et al.
Published: (2022-10-01) -
IMPERIALISMO NA AMÉRICA LATINA. AS AÇÕES DO TIO SAM NOS ANDES BOLIVIANOS
by: Adilson Amorim de Sousa, et al.
Published: (2023-06-01)